Our Recommendations
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
New Publications
- WHO guidelines on meningitis diagnosis, treatment and care: executive summary (2025)
- Cinco momentos para la higiene de manos (2021)
- Five moments for hand hygiene (2021)
- Risk communication and community engagement readiness and response toolkit: mpox (2024)
- Risk communication and community engagement readiness and response toolkit: yellow fever (2024)
Filter
833
Featured
Recommendations
146
New Publications
207
Language
Document type
No document type
367
Guidelines
132
Training Material
44
Manuals
41
Situation Updates
41
Studies & Reports
37
Fact sheets
35
Online Courses
34
Resource Platforms
32
Infographics
30
Strategic & Response Plan
29
Videos
10
Dashboards/Maps
1
Countries / Regions
Brazil
27
Congo, Democratic Republic of
25
Africa
21
Nigeria
19
Guinea
16
Global
16
Latin America and the Carribbean
16
Sierra Leone
15
Liberia
14
Senegal
13
Germany
13
Rwanda
12
Burkina Faso
12
Western and Central Europe
10
Côte d’Ivoire / Ivory Coast
10
Russia
10
Angola
10
Mozambique
9
Mali
9
West and Central Africa
8
Uganda
8
India
8
South Africa
6
Ethiopia
6
Indonesia
6
Ghana
5
Syria
5
Paraguay
5
Portugal
5
East and Southern Africa
5
Yemen
5
Somalia
5
Colombia
4
Kenya
4
Togo
4
Burundi
4
Peru
4
Argentina
4
Sri Lanka
4
South Sudan
4
Madagascar
4
China
3
Niger
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Central African Republic
3
Chad
3
Nepal
2
Cameroon
2
Afghanistan
2
Zimbabwe
2
Venezuela
2
Bolivia
2
Bangladesh
2
Vietnam
2
Serbia
1
Turkey
1
Benin
1
Gambia
1
Iran
1
Kyrgyzstan
1
Philippines
1
USA
1
Haiti
1
Asia
1
Dominican Republic
1
Guinea-Bissau
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Western Pacific Region
1
Turkmenistan
1
Japan
1
United Kingdom
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Sudan
1
Honduras
1
Zambia
1
Ecuador
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
147
Key Resources
134
Countries
90
Public Health
54
Capacity Building
43
Pharmacy & Technologies
25
Women & Child Health
4
MSF often responds to outbreaks of cholera in the countries we work. But how do we set up our cholera treatment centres to ensure our patients get the best care possible - and that the disease doesn't spread? Learn more about the layout and activities of an MSF cholera treatment centre in this inter...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
On a need’s basis, the Immunization Analysis and Insights, Vaccine Preventable Diseases (VPD) Surveillance and Risk Assessment Team of the World Health Organization (WHO) posts expression of interest (EOI) calls, inviting manufacturers of specified technologies (in vitro diagnostics also known as ...
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...
In line with the Defeating meningitis by 2030: a global road map, the WHO guidelines on meningitis diagnosis, treatment and care Executive Summary provides a summary of the evidence-based recommendations for the clinical management of children and adults with community-acquired meningitis, including...
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedi...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
Le 14 août, l’Organisation mondiale de la Santé (OMS) déclarait que l’épidémie de variole simienne, dite Mpox, était une « urgence sanitaire internationale », après une flambée des cas en Afrique. Le lendemain, un cas était déclaré en Suède. La branche européenne de l’OMS estime...
The safety of children is a top concern for parents and school authorities in the current mpox outbreak, as those
under 15 face elevated risks, particularly in the hardesthit Northwestern and Eastern regions of the Democratic Republic of the Congo.
Infographic
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o...
La République démocratique du Congo (RDC) mise sur la surveillance communautaire pour mieux riposter à la variole simienne appelée en anglais Mpox. En 2023, plus de 14 000 cas de Mpox ont été détectés. Le pays, avec l’appui de ses partenaires, forme les relais communautaires pour la sensib...
Uganda confirmed the first cases of mpox on 24 July 2024 following the confirmation of two case-patients from Kasese District, Bwera Hospital by the Uganda Virus Research Institute (UVRI) through a routine sentinel surveillance system. Cumulatively, 80 confirmed cases of mpox have been registered.
The tab is the result of a preliminary landscape of therapeutics licensed or under development for Mpox
There has been a global outbreak of mpox since 2022; this outbreak has been caused by the strain of mpox virus called Clade 2 and has affected around 116 countries worldwide. The current surge in cases is being driven by the rapid spread of a different strain – Clade 1b – which is predominantly ...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for dengue fever outbreaks. The toolkit conta...
